RVMD - Revolution Medicines - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RVMD is currently covered by 20 analysts with an average price target of $186.09. This is a potential upside of -$21.59 (-10.4%) from yesterday's end of day stock price of $207.68.

Revolution Medicines's activity chart (see below) currently has 197 price targets and 204 ratings on display. The stock rating distribution of RVMD is 96.97% BUY and 3.03% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.67% with an average time for these price targets to be met of 185.54 days.

Highest price target for RVMD is $320, Lowest price target is $73, average price target is $186.09.

Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 24-Sep-2026. First documented stock forecast 09-Mar-2020.

Best performing analysts who are covering RVMD - Revolution Medicines:

Cory Kasimov Laura Prendergast Michael Schmidt Kelsey Goodwin

Currently out of the existing stock ratings of RVMD, 64 are a BUY (96.97%), 2 are a HOLD (3.03%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Jul-2025

$267

$60.36 (29.21%)

$73

12 days ago
(24-Sep-2026)

2/3 (66.67%)

$67.14 (33.59%)

97

Buy Since 16-Jul-2024

$265

$58.36 (28.24%)

$80

15 days ago
(21-Sep-2026)

3/4 (75%)

$72.24 (37.48%)

74

Buy Since 16-Jan-2024

$230

$23.36 (11.30%)

$215

27 days ago
(09-Sep-2026)

6/7 (85.71%)

$22.32 (10.75%)

118

Buy Since 14-Dec-2022

$275

$68.36 (33.08%)

$240

1 months 5 days ago
(31-Aug-2026)

28/32 (87.5%)

$69.43 (33.77%)

184

Buy Since 28-Feb-2023

$275

$68.36 (33.08%)

$92

1 months 8 days ago
(28-Aug-2026)

2/4 (50%)

$67.12 (32.29%)

432

Show more analysts

Please expand the browser size to see the chart

What is RVMD (Revolution Medicines) average time for price targets to be met?

On average it took 186 days for the stock forecasts to be reached, with an average price target met ratio of 92.67%.

Which analyst most recently updated their price target on RVMD (Revolution Medicines)?

Andrea Tan

Which analyst has the most public recommendations on RVMD (Revolution Medicines)?

Andrea Tan works at GOLDMAN SACHS and has 11 price targets and 8 ratings on RVMD

Which analyst is the currently most bullish on RVMD (Revolution Medicines)?

Cory Kasimov with the highest potential upside of $113.36

Which analyst is the currently most reserved on RVMD (Revolution Medicines)?

Chris Shibutani with the lowest potential downside of -$183.64
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?